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During bacterial sepsis, proinflammatory cytokines
contribute to multiorgan failure and death in a pro-
cess regulated in part by cytolytic cell granzymes.
When challenged with a sublethal dose of the identi-
fied mouse pathogen Brucella microti, wild-type
(WT) and granzyme A (gzmA)/ mice eliminate the
organism from liver and spleen in 2 or 3 weeks,
whereas the bacteria persist in mice lacking perforin
or granzyme B as well as in mice depleted of Tc cells.
In comparison, after a fatal challenge, only gzmA/
mice exhibit increased survival, which correlated
with reduced proinflammatory cytokines. Depletion
of natural killer (NK) cells protects WT mice from
sepsis without influencing bacterial clearance and
the transfer of WT, but not gzmA/ NK, cells into
gzmA/ recipients restores the susceptibility to
sepsis. Therefore, infection-related pathology, but
not bacterial clearance, appears to require gzmA,
suggesting the protease may be a therapeutic target
for the prevention of bacterial sepsis without
affecting immune control of the pathogen.
INTRODUCTION
Cytotoxic CD8+ T (Tc) cells and natural killer (NK) cells use death
ligands, granule exocytosis, and soluble proinflammatory cyto-
kines to combat intracellular pathogens and cell transformation420 Cell Reports 8, 420–429, July 24, 2014 ª2014 The Authors(Biron, 1994; Russell and Ley, 2002). Conventionally, granule
exocytosis and death ligands exert this function by inducing
target cell death; meanwhile, interferon g (IFNg) and tumor ne-
crosis factor alpha (TNFa), among other cytokines, participate
in the development of beneficial inflammatory responses by
modulating the activity of macrophages and dendritic cells.
However, if these pathways are not properly regulated, autoim-
mune and inflammatory disorders may develop.
Granule exocytosis may be described as a specialized form of
intracellular protein delivery. Here, a pore-forming protein per-
forin (perf) aids the translocation of a family of serine proteases
(granzymes [gzms]) into the cytosol of target cell (Voskoboinik
et al., 2006). The gzms are ultimately responsible for target cell
death by activating variousmechanisms that execute the offend-
ing cell. Among the described proteinases (five in humans and
ten in mice), gzmA and gzmB are the most abundant and thor-
oughly characterized (Bovenschen and Kummer, 2010; Chowd-
hury and Lieberman, 2008; Grossman et al., 2003). Whereas
GzmB is clearly cytotoxic (Bleackley, 2005; Trapani and Sutton,
2003), the supposition that gzmA only induces cell death is
controversial (Lieberman, 2010; Metkar et al., 2008). Gzms
have been shown to inactivate viral particles, degrade extracel-
lular matrix, and induce adherent cells tomanufacture proinflam-
matory cytokines (Anthony et al., 2010a; Froelich et al., 2009;
Hendel et al., 2010; Pardo et al., 2009; Romero and Andrade,
2008). Specifically, gzmA, gzmK, and gzmM in vitro may pro-
mote the release of proinflammatory cytokines from macro-
phages and gzmB may enhance the proinflammatory activity
of interleukin 1a (IL1a) (Afonina et al., 2011). More compellingly,
gzmA- or gzmM-deficient mice resist lipopolysaccharide (LPS)-
induced septic shock (Anthony et al., 2010a; Metkar et al.,
2008), suggesting that gzmA and gzmM may contribute to the
pathogenesis of bacterial sepsis.
Bacterial sepsis is presumed to be caused by uncontrolled
production of proinflammatory cytokines (IL6, TNFa, and IL1b)
secreted by macrophages (Angus and van der Poll, 2013). This
outcome depends upon a process where macrophages are
overactivated by recognition of bacterial pathogen-associated
molecular patterns (PAMPs). They are recognized by Toll-like re-
ceptors (TLRs) and other pattern recognition receptors in both
plants and animals. Bacterial LPS, an endotoxin found on the
bacterial cell membrane, is a prototypical PAMP (Van Amersfoort
et al., 2003). Endotoxin is a potent mediator of gram-negative
bacteria-induced sepsis, but other bacterial components also
contribute to the inflammatory response (e.g., peptidoglycan;
Van Amersfoort et al., 2003). Although macrophages are critical
promoters of septic shock, other cell types likely contribute to
this pathological outcome including Tc and NK cells (Sherwood
et al., 2003). Several studies have shown a positive correlation
between the severity of sepsis and the expression of gzms A
and B in lymphocytes (Schaer et al., 2006; Zeerleder et al.,
2005). Whether the contribution of perf and gzms to the pathol-
ogy observed during sepsis is due to the induction of cell death
or to proinflammatory effects is unknown (Hashimoto et al.,
2000; Wesche-Soldato et al., 2007).
Unfortunately, the animal model of sepsis induced by LPS
does not fully recapitulate the many facets of the septic shock
response (Rittirsch et al., 2007). There is a need for animal
models where the clinical signs of sepsis develop after exposure
to endogenous bacterial pathogens. To test whether Tc/NK-cell-
derived gzms control a replicating pathogen as well as paradox-
ically contribute to sepsis, we have usedBrucellamicroti, a newly
described mouse pathogen. Brucella microti, a member of the
Brucella genus isolated from wild rodents, is an intracellular
facultative pathogen that replicates primarily in macrophages
and, in contrast to otherBrucella spp, produces systemic bacter-
emia and fatal sepsis (Jime´nez de Bagu¨e´s et al., 2010, 2011).
RESULTS
Role of Cytolysis in the Control of Brucella microti
Infection
Overall, we asked whether alteration in the levels of cytolytic
components might curtail inflammation during sepsis without
affecting control of the bacterial infection and, thus, could
constitute a selective therapeutic approach. In contrast to Bru-
cella spp, which are nontoxic for mice, inoculating wild-type
(WT) C57Bl6 (B6) mice with 106 colony-forming units (cfu) of Bru-
cella microti causes sepsis within 1 week (Alcaraz et al., 2010,
Am. Coll. Vet. Pathol., conference; Jime´nez de Bagu¨e´s et al.,
2010). Thus, we applied a biological tool to study the control of
bacterial sepsis in a mouse model. Brucella spp infect the host
by varied routes including inhalation, inoculation through the
conjunctival sac, ingestion of contaminated food, or through
breaks in the skin. We chose intraperitoneal (i.p.) inoculation
because this form of infection mimics entry through skin cuts
(Turner et al., 2011).
Todetermine the contribution ofCD8+ T cells andNKcells in the
control of infection,weperformed in vivo immunodepletion exper-iments with anti-CD8a and anti-NK1.1 in mice inoculated with a
sublethal dose (105 cfu) of bacteria. Only the depletion of CD8+
T cells increased the splenic bacterial load at 7 and 14 days and
in liver by 14 days (Figure 1A) whereas most WT animals had
cleared the bacteria. The efficacy of the depletion protocol was
verified by fluorescence-activated cell sorting (FACS) analysis of
splenic NK, CD8+ T cells, macrophages (CD11b+/CD11c), and
dendriticcells (CD11c+;Figure1A, rightpanel).Next,weexamined
thecytolyticpathwaysofTccells thatmightcontrol infection invivo
by inoculatingWTandvariousknockout (KO)micewitha sublethal
cfu of B. microti andmonitoring bacteria replication in spleen and
liver. Compared to WT mice, bacterial clearance from the spleen
(Figure 1B) was delayed in perf/, perfxgzmAxB/, gzmB/,
and gzmAxB/ and was similar to gzmA/, Fas/, and gld
mice. The time of maximum bacterial load (day 3) was similar
among the animal groups. However, differences between WT
and perf/, perfxgzmAxB/, gzmB/, and gzmAxB/ groups
werenotedat7days, the timewhen theWTanimalsbegan toclear
infection. These differences then becamemore pronounced after
14 and 21 days. In the liver, the results were less dramatic; here,
only perf/ and perfxgzmAxB/ mice showed higher cfu than
WT mice. Finally, we found that the level of IFNg in serum was
similar for WT, perfxgzmAxB/, gzmAxB/, and Fas/ mice
after 3 and 7 days (Figure 1C), suggesting that defects in
perfxgzmAxB/ and gzmAxB/micewere not due to the failure
of these animals to respond to B. microti inoculation. Further
supporting this possibility, isolated CD4+ and CD8+ T cells from
WT and KO mice produced similar levels of IFNg after restimula-
tion with Brucella antigens in vitro (Figure 1D).
Tc Cells Are Activated during B. microti Infection In Vivo
whereas perf and gzmB Are Necessary to Inhibit
B. microti Replication in Primary Macrophages
The in vivo experiments indicate that CD8+ T cells and their cyto-
lytic mediators, perf and gzmB, participate in the control of
B. microti infection. Tc cells from mice infected with B. microti
expressed gzmA, gzmB, and gzmK, indicating that these cells
were activated during infection in vivo (Figure S1). Expression
of the granzymes was accompanied by an increase in the ability
of the ex vivo WT Tc cells to inhibit B. microti replication in bone-
marrow-derived macrophages (BMDM) (Figure S2A). Tc cells
from noninfected mice were unable to inhibit B. microti replica-
tion, indicating that the observed effects were antigen specific
(Figure S2B). We then compared the ability of Tc cells from
WT, perfxgzmAxB/, gzmA/, gzmB/, gzmAxB/, and
gld mice to control B. microti replication in BMDMs. Bacterial
growth was less reduced for Tc cells lacking perf or gzmB
compared to WT or gzmA-deficient Tc cells (Figure 2A).
To directly test in our model that Tc control B. microti growth,
we presumed that Tc cells containing perf and gzmB would
reduce bacterial proliferation by eliminating infected BMDMs.
Thus, in parallel experiments described for Figure 2A, we tested
whetherB.-microti-infectedmacrophages were killed by Tc cells
containing perf and gzmB.WhereasB.microtiwas not toxic (Fig-
ure 2B; medium), ex vivo Tc cells isolated fromWT and gzmA/
B.-microti-infected mice induced a typical apoptotic phenotype
characterized by phosphatidylserine translocation (annexin V
staining) without membrane permeabilization (7AAD staining).Cell Reports 8, 420–429, July 24, 2014 ª2014 The Authors 421
(legend on next page)
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The levels of apoptosis induced by WT and gzmA/ Tc cells
were significantly higher than observed for gzmB/,
gzmAxB/, and perfxgzmAxB/ Tc cells, indicating that perf
and gzmB, but not gzmA, were primarily responsible for the
destruction of BMDM infected with B. microti. Notably, Tc cell
activity appears specific to B. microti because WT Tc cells
from uninfected mice did not induce apoptosis (Figure 2B). The
levels of apoptosis induced by Brucella-specific Tc cells against
infected BMDMs was similar to lymphocytic choriomeningitis vi-
rus (LCMV)-specific Tc cells against noninfected, gp33-pulsed
BMDMs, indicating a high level of Tc cell activation during
B. microti infection.
Supporting a role for macrophage apoptosis in the control of
bacterial replication, we found that the number of bacteria in
macrophages treated with the protein kinase C inhibitor stauro-
sporine was significantly lower than the untreated controls after
24 hr (Figure S3A). This outcome was observed for cells incu-
bated with staurosporine for 24 hr, although apoptosis was
evident after 7 hr (Figure S3C). Because B. microti starts to repli-
cate in BMDM after 7 hr (data not shown), this finding suggests
that apoptosis per se does not kill the bacteria but inhibits repli-
cation in the cells undergoing apoptosis. Supporting this possi-
bility, if these macrophages (infected for 7 hr in vitro) acted as
the source of B. microti for infection in vivo, a significantly lower
level of infection was observed compared to viable infected
BMDM (Figure S3B). Altogether, these experiments suggest
that perf and gzmB indeed control B. microti replication by
inducing apoptosis in cells that harbor the pathogen.
GzmA Deficiency Enhances Mouse Survival after
Brucella microti Infection and Reduces Disseminated
Intravascular Coagulation and the Levels of
Proinflammatory Cytokines In Vivo
GzmA does not appear necessary to eradicate B. microti. We
therefore asked whether the protease might contribute to sepsis
in mice challenged with a lethal dose of the organism (Alcaraz
et al., 2010, Am. Coll. Vet. Pathol., conference; Jime´nez de
Bagu¨e´s et al., 2010) by assessing survival, bacteremia, dissem-
inated intravascular coagulation (DIC), and the level of proinflam-
matory cytokines. WT, gzmA/, gzmB/, perf/, and
perfxgzmAxB/ mice were inoculated with 106 cfu of
B. microti, and survival was monitored for 21 days. Approxi-
mately 60% of WT, gzmB/, perf/, and perfxgzmAxB/
mice died during the first 10 days (Figure 3A). In contrast,Figure 1. Role of CD8+ T and NK Cells and Their Cytolytic Mediators i
(A) NK and/or CD8 T+ cells in WT B6 mice were depleted using anti-NK1.1 and/or
with B. microti (105 cfu) and the number of cfu in liver and spleen at 7 and 14 day
replicates performed in two independent experiments; *p < 0.05; **p < 0.01; ***p <
panels), splenocytes were isolated from three animals of each group, stained with
Numbers correspond to the percentage of cells in each quadrant.
(B) Mice were infected i.p. with B. microti (105 cfu), and the number of cfu in live
mean ± SEM of the indicated number of biological replicates performed in four i
group with the control group (B6).
(C) The level of IFNg was quantified in serum from indicated animals 3 and 7 d
replicates performed by duplicates.
(D) Ex vivo production of IFNg by CD4 and CD8 T cells was measured in splenocyt
in bar graphs on the right represent the mean ± SEM from two independent ex
fluorescein isothiocyanate; PE, phycoerythrin.gzmA-deficient animals were spared (20% died). Remarkably,
if mice received a highly lethal dose (107 cfu), all WT animals
died in 7 days, whereas 20% of gzmA/ mice survived (data
not shown). These data indicate that inflammation induced by
gzmA contributes to septic response induced byB.microti infec-
tion and provides biologically relevant confirmation that gzmA
deficiency protects mice from LPS-induced septic shock
(Anthony et al., 2010b; Metkar et al., 2008). We cannot conclude
if this effect depends on the presence of perf. Here, both perf/
and perfxgzmAxB/ mice were just as susceptible as WT mice
to sepsis whereas bacteremia was significantly higher in
perfxgzmAxB/ than gzmA/ mice (Figure S4). Emphasizing
that the lethal effect of Brucella was TLR-dependent, TLR4/
mice survival was significantly greater than for WT animals
(Figure 3).
During sepsis, bacteria circulate throughout the vasculature,
disseminating in multiple organs. Accordingly, B. microti was
identified in blood, liver, spleen, brain, kidney, and lung 3 days
after receiving a lethal dose inoculation (Figure 3B). Again, no dif-
ference was observed between WT and gzmA/ mice.
DIC is a catastrophic complication of sepsis. Accordingly, the
improved survival of gzmA-deficient mice was associated with a
reduction in DIC (Figure 3C). After inoculation with 106 cfu of
B. microti, gzmA/ mice had lower prothrombin times and
higher platelet counts than WT mice. The level of serum alanine
aminotransferase (ALT) was also lower in gzmA/ mice,
although the values did not reach statistical significance.
Finally, to verify that protection was partially due to reduced
serum level of proinflammatory cytokines, we monitored the
concentrations of IL1a, IL1b, TNFa, IL6, IFNg, and MIP1a
in WT and gzmA/ mice during the 72 hr after lethal bacterial
inoculation. Compared to levels observed in mice receiving a
nonlethal dose (105 cfu), mice that received 106 cfu had sig-
nificantly higher level of cytokines (Table S1). When cytokine
levels were measured in animals infected with 106 cfu, the
concentration of all cytokines except IFNg was significantly
lower in gzmA/ than in WT animals (Figure 3D).
Mice Depleted of NK Cells Survive B. microti Infection,
and the Transfer of WT NK Cells into gzmA/ Mice
Restores Susceptibility to Sepsis
We then determined the cell type that might be the source of
gzmA during sepsis induced by B. microti infection. Because
animals die after 3 days, we hypothesized that inflammationn the Control of B. microti Infection in Spleen and Liver
anti-CD8amonoclonal antibody (mAb). Subsequently, mice were infected i.p.
s was quantified. Data are mean ± SEM of the indicated number of biological
0.001, comparing each group with the control group (Iso IgG). In parallel (right
CD3/CD8, CD11b/CD11c, and NK1.1 mAbs and analyzed by flow cytometry.
r and spleen was determined 3, 7, 14, or 21 days later. Data are presented as
ndependent experiments; *p < 0.05; **p < 0.01; ***p < 0.001, comparing each
ays after infection. Data are presented as mean ± SEM from four biological
es frommice 7 days after infection as indicated in materials andmethods. Data
periments combining duplicate samples. APC, antigen-presenting cell; FITC,
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Figure 2. Ex Vivo B. microti-Specific Tc
Cells Use perf and gzmB to Control Bac-
terial Replication and Induce Apoptosis in
BMDMs In Vitro
B6, gzmA/, gzmB/, gzmAxB/, and
perfxgzmAxB/ mice were infected with
B. microti i.p. (105 cfu). CD8+ cells were enriched
from spleen using MACS 7 days afterward and
incubated with BMDM from WT B6 mice infected
withB.microti. After 24 hr, cells were lysed and the
number of cfu was determined (A). In parallel, the
percent apoptotic macrophages (annexin V/7AAD
staining) was quantified (B). As a control, Tc cells
from LCMV-infected B6 WT mice were incubated
with BMDMs labeled with the immunodominant
LCMV peptide gp33. A representative experiment
is shown as dot plots. Numbers show the cell
percentage in each quadrant. Data are presented
as mean ± SEM from three independent experi-
ments where samples were measured in triplicate.
*p < 0.05; **p < 0.01; ***p < 0.001, comparing each
group with the group treated with B6 (WT) Tc cells.induced by gzmA would be executed by NK cells from the innate
arm of the immune system. We analyzed the survival of mice in
which NK cells were depleted after inoculation with a lethal
dose. After depletion of NK cells, 78% of mice survived bacterial
sepsis compared to 27% of mice treated with control immuno-
globulin G (IgG) (Figure 4A). However, NK cell depletion did not
alter bacterial clearance in spleens of surviving mice (Figure 4B).
In addition, NK cells isolated from mice infected with a lethal
dose of B. microti expressed gzmA (Figure 4C).424 Cell Reports 8, 420–429, July 24, 2014 ª2014 The AuthorsTo confirm that NK cells are indeed the
source of gzmA during sepsis induced by
B. microti, we performed transfer experi-
ments in which magnetic-activated cell
sorting (MACS)-enriched splenic NK cells
from noninfected WT or gzmA/ mice
were isolated and transferred to gzmA/
mice. Subsequently, mice were chal-
lengedwith 106 cfuB.microti and survival
was monitored. Survival of gzmA-defi-
cient mice was significantly higher than
WTmice (Figure 4D). Notably, the survival
of gzmA-deficient mice in which WT NK
cells had been transferred was now
similar to WT mice; meanwhile, transfer
of gzmA-deficient NK cells did not alter
the susceptibility to sepsis of gzmA/
mice. These data strongly confirm that
gzmA associated with NK cells are regu-
lating the septic response during infec-
tion with the mouse bacterial pathogen
B. microti.
DISCUSSION
The genesis of septic shock remains
poorly understood and has resisted treat-ment with a variety of therapeutics (Angus and van der Poll,
2013). Recent efforts have focused on alterations within the im-
mune system to identify treatment options (Chiche et al., 2011). A
major drawback in dissecting the innumerable steps that culmi-
nate in sepsis has been the relative lack of animal models to
study this major health problem. We have employed a mouse
gram-negative bacterial pathogen, B. microti, to analyze the ca-
pacity of Tc and NK cells to control bacterial infection as well as
contribute to the development of sepsis. Our data show that WT
Figure 3. GzmA-Deficient Mice Survive
Sepsis Induced by B. microti Infection by
a TLR4-Dependent Mechanism
(A) B6 (WT), B10 (WT), perf/, perfxgzmAxB/,
gzmA/, gzmB/, and TLR4/ mice were in-
fected i.p. with B. microti (106 cfu), and survival was
monitored for 21 days. The data correspond to the
indicated number of mice combined from two in-
dependent experiments. *p < 0.05; **p < 0.01; ***p <
0.001.
(B) B6 (WT) and gzmA/ mice were infected i.p.
with 106 cfu B. microti, and the number of cfu in
blood, lung, brain, kidney, liver, and spleen was
determined 3 days later.
(C and D) B6 (WT) and gzmA/mice were infected
i.p. with 106 cfu B. microti, and prothrombin time,
platelet counts, and ALT (C) or cytokine (D) levels
were measured in plasma or serum, respectively, at
the indicated times postinfection as described in
Experimental Procedures. Data are represented as
mean ± SEM of four biological replicates performed
by duplicates (C) or seven biological replicates
performed by duplicates in two independent ex-
periments (D). *p < 0.05; **p < 0.01; ***p < 0.001.mice Tc cells participate in the control of B. microti infection
in vivo and in vitro with the aid of perf and gzmB. However, other
forms of immunity likely contribute to bacterial clearance
because mice marginally reduce bacterial replication despite
the absence of Tc cells or perf and gzmB. In marked contrast,
gzmA contributes to the increased proinflammatory cytokine
response during sepsis, a process that depends on the presence
of NK cells.
What is the mechanism underlying the control of B. microti
by perf and gzmB, and why would gzmA be dispensable? Unlike
tumor models, understanding the immune etiopathogenesis of a
pathogen that survives in macrophages is more complicated.
For example, perf and gzmB certainly could kill an infected
macrophage; however, Brucella-filled apoptotic bodies would
be engulfed by adjacent macrophages allowing the bacteria to
have a replicative advantage. Here, the inflammatory microenvi-
ronment would be predicted to enhance the capacity ofCell Reports 8, 420bystander macrophage to kill these in-
fected apoptotic bodies, a function served
by gzmA. Inasmuch as gzmA induces cy-
tokines that would augment the bacteri-
cidal activity of monocyte-macrophages,
it is unclear why the protease does not
aid clearance of the pathogen. Our data
do not unequivocally discount a protective
role for gzmA in the immune response
against B. microti but suggest that other
cell types that do not respond to gzmA
may be bacterial reservoirs. Finally, the
phagocytosis of infected apoptotic cells
by bystander dendritic cells would enable
cross priming of T cells enhancing the
elimination of pathogens, a scenario that
has been reported for Salmonella (Yrlidand Wick, 2000) and Mycobacterium tuberculosis (Schaible
et al., 2003). However, these pathways have not been examined
in the control of Brucella spp.
GzmA deficiency appears to dramatically protect mice from
sepsis during B. microti infection. A similar safeguard occurs
after NK cell depletion, suggesting that NK cells are the source
of proinflammatory gzmA during bacterial sepsis. Confirming
this possibility, the transfer of NK cells from WT mice into
gzmA/ mice enhances the susceptibility of mice to a septic
response comparable to WT mice.
The results reported here directly corroborate our recent
observation that gzmA deficiency increases the resistance of
mice to septic shock induced by LPS (Metkar et al., 2008), a
finding confirmed by others (Anthony et al., 2010b). Neverthe-
less, these studies did not clarify whether the resistance of the
gzmA KO mice was related to the amelioration of the cytokine
storm induced by LPS because the serum levels of–429, July 24, 2014 ª2014 The Authors 425
Figure 4. NK Cell Depletion Protects Mice
from Sepsis, and Transfer of WT NK Cells
into gzmA-DeficientMice Restores Suscep-
tibility of gzmA/ Mice to Sepsis
(A and B) Control IgG-treated or NK-depleted B6
mice were infected i.p. with 106 cfu of B. microti,
andmouse survival wasmonitored during 21 days.
(A) Survival curves corresponding to 20 biological
replicates from two independent experiments.
*p < 0.05; **p < 0.01; ***p < 0.001. (B) Surviving
animals were sacrificed and the numbers of cfu in
spleen were determined as described in the
Experimental Procedures. Data are presented as
mean ± SEM of cfu in spleen of each group; *p <
0.05; **p < 0.01; ***p < 0.001.
(C) B6 and gzmA/ mice were mock treated
(naive) or infected with 106 cfu of B. microti i.p.,
and 3 days after infection, expression of gzmA
was analyzed in MACS-enriched NK cells by flow
cytometry.
(D) NK cells were enriched by MACS from WT or
gzmA/ mice and inoculated (1 3 106 cells/
mouse) i.p. in gzmA/ mice. Subsequently, con-
trol or transferred mice were infected i.p. with 106
cfu of B. microti and mouse survival was moni-
tored during 21 days. *p < 0.05; **p < 0.01; ***p <
0.001. Data correspond to the indicated number of
biological replicates from at least two independent
experiments.proinflammatory cytokines were not monitored. Until now,
whether gzmA is indeed a physiological modulator of inflamma-
tion has been controversial. Furthermore, to maintain the ho-
meostatic milieu, the immune system must balance the proin-
flammatory response necessary to control a bacterial infection
without inducing immunopathology.
Recent evidence suggests that several gzms including gzmA,
gzmB, and gzmK possess perf-independent extracellular func-
tions that could influence hemostasis, vascular permeability,
and other events that are considered hallmarks of sepsis (Hendel
et al., 2010; Hiebert and Granville, 2012). Because perf/ and
perfxgzmAxB/ mice are equally susceptible to sepsis as WT
mice, we are unable to determine whether the participation of
gzmA occurs intra- or extracellularly. In comparison, perf defi-
ciency has been reported to protect mice from sepsis induced
by LPS (Anthony et al., 2010b). Addressing this conflict, perf defi-
ciency clearly increases the replication of B. microti (Figure S4).
Thus, the beneficial ‘‘anti-inflammatory’’ effect in mice lacking
both perf and gzmA is likely reduced by the higher bacterial
load observed in these animals in comparison with animals
that lack only gzmA.
Our data indicate that inflammation induced by gzmA in vivo
plays a critical role in the development of sepsis associated
with B. microti infection. Indeed, the absence of gzmA substan-
tially protects mice from the lethal effects of B. microti where426 Cell Reports 8, 420–429, July 24, 2014 ª2014 The Authorssurvival correlated inversely with serum
levels of IL6, TNFa, IL1a, IL1b, and
MIP1a. Importantly, IFNg, the only cyto-
kine that is present at similar levels inboth WT and gzmA KO mice, is not produced by macrophages
and thus is predicted to be unaffected by gzmA. Thus, the
reduced level of cytokines in the absence of gzmA is likely
due to the lack of protease-mediated induction of proinflamma-
tory responses in macrophages, which are considered a major
source of these cytokines during bacterial infections (Benoit
et al., 2008). The reduction in the inflammatory response could
also explain the amelioration of DIC parameters observed in
gzmA-deficient mice, because it has been reported that inflam-
matory cytokines like IL1a/ILb, IL6, or TNFa contribute to the
activation of the coagulation cascade by enhancing the pro-
duction of tissue factor and decreasing the expression of anti-
coagulation factors (van der Poll et al., 2000). Alternatively, it
has been described that both gzmA and gzmK, which express
similar cleavage specificity as gzmA, are able to activate the
protease-activated receptors (PAR) in neurons and fibroblasts
(Cooper et al., 2011; Suidan et al., 1994). These receptors are
involved in platelet activation and thrombosis upon activation
by thrombin, and accordingly, one could speculate that extra-
cellular gzmA may directly promote thrombosis. However, it
is not clear if gzmA-mediated PAR activation in platelets is suf-
ficient to promote platelet aggregation (Suidan et al., 1996), and
thus, this hypothesis requires further research.
Howdoes aprotease fromNKcells regulatemacrophage func-
tion? Various studies have established that macrophage/NK cell
crosstalk occurs during bacterial infections (Hamerman et al.,
2004; Nedvetzki et al., 2007), probably due to the interaction of
NK-associated TLR ligandswithmacrophage-associated recep-
tors. Notably, it has been reported that LPS stimulates the
expression of the activating NKG2D ligand MicA on macro-
phages through a TLR-dependent mechanism (Eissmann et al.,
2010). Ligation of NKG2D would stimulate the secretion of cyto-
toxic granule toward the interacting macrophage where the pro-
tease then modulates macrophage activity.
We have shown that two members (gzmB and gzmA) ex-
pressed by Tc and NK cells differentially contribute bacterial
immunopathogenesis. By targeting gzmA, one may ameliorate
bacteria-associated sepsis without compromising the ability of
the immune system to control infection. This finding opens the
possibility of treating inflammatory sepsis without causing
immunosuppression.
EXPERIMENTAL PROCEDURES
Mouse Strains
Inbred C57BL/6 (B6) and mouse strains deficient for granzyme A (gzmA/),
granzyme B (gzmB/), granzyme A and B (gzmAxB/), perforin (perf/),
perforin and granzyme A and B (perfxgzmAxB/), Fas (Fas/), and gld
(FasL mutant) bred on the B6 background and inbred C57BL/10 and a mouse
strain with a spontaneous mutation for TLR4 were provided by Markus Simon
and Marina Freudenberg (TLR4) from the Max-Planck-Institut fu¨r Immunbio-
logie, Freiburg and bred at the Centro de Investigacio´n y Tecnologı´a Agroali-
mentaria (CITA). Their genotypes were periodically analyzed as described
(Pardo et al., 2008). Mice of 8–12 weeks of age were used in all experiments.
Bacterial Strain and Determination of cfu
B. microti strain CCM4915 was grown to stationary phase in tryptic soy broth
(Difco Laboratories), with shaking, at 37C for 24 hr. The number of living
bacteria in a sample was determined by counting the cfu after plating serial
dilutions onto tryptic soy agar plates as described previously (Jime´nez de
Bagu¨e´s et al., 2011). In addition, the smooth phenotype of the strains was veri-
fied in all cases by crystal violet staining (Jime´nez de Bagu¨e´s et al., 2010).
Replication of Brucella microti In Vivo
A sublethal dose (105 cfu) of B. microti was injected intraperitoneally, and after
different time points, the mice were euthanized by CO2 asphyxiation and
blood, spleen, and liver samples were collected aseptically. The spleen and
liver were weighed, homogenized, serially diluted, and plated onto tryptic
soy agar for culture and counting of viable Brucella organisms after 24 to
48 hr of growth at 37C.
In Vivo Depletion of NK and CD8+ T Cells
Depletion of NK and CD8+ T cells was performed using the rat anti-NK1.1
monoclonal antibody (mAb) pk136 and an anti-mouse CD8a mAb (53-6.72),
respectively, as indicated in Supplemental Experimental Procedures.
Replication of Brucella microti in BMDM In Vitro
Macrophages were differentiated from mouse bone marrow during 6 days as
described previously (Aporta et al., 2012) and in Supplemental Experimental
Procedures. For replication experiments in vitro, 4 3 105 macrophages/well
were seeded in 24-well plates and infected with B. microti at a multiplicity of
infection of 25:1 for 45min at 37C, 5%CO2. At this time point, in some exper-
iments, staurosporine (500 nM) or MACS-enriched (positive selection; Miltenyi
Biotec) splenic Tc or NK cells fromWT or KOmice were added. Subsequently,
medium was removed and cells were washed with PBS and further incubated
with Dulbecco’s modified Eagle’s medium 10% fetal calf serum containing
30 mg/ml of gentamycin. After 24 hr, macrophages were lysed with Triton
X-100 0.1%, and cfu number was determined.Flow Cytometry
Intracellular expression of granzymes and IFNg were analyzed by FACS as
previously described (Joeckel et al., 2011; see the Supplemental Experimental
Procedures for more details).
Cytotoxicity Assay
Tc cells were isolated from mouse spleen using MACS-positive selection
(Miltenyi Biotec) and used for cytotoxic analyses on target cells as previously
described (Pardo et al., 2008; see the Supplemental Experimental Procedures
for more details).Evaluation of Sepsis Induced by Brucella microti Infection
B6, KO, and NK-depleted mice were infected with 106 cfu (lethal dose in B6
mice) of B. microti, and mouse survival was monitored during 21 days. In addi-
tion, somemice were sacrificed after 6, 12, 24, and 72 hr of infection, and IL1a,
IL1b, IL6, IFNg, TNFa, and MIP1a levels in serum (Multiplex Bead Array Sys-
tem; Luminex; Millipore) or prothrombin time, platelet counts, and ALT levels
in plasma were analyzed.Statistical Analyses
Statistical analysis was performed using GraphPad Prism software. The differ-
ence between means of paired or unpaired samples was performed using the
respective t test. Survival curves were compared using both the log rank test
and the Gehan-Wilcoxon test. The results are given as the confidence interval
(p) and are considered significant when p < 0.05. Biological replicates are
considered as the number of individual mice.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2014.06.012.AUTHOR CONTRIBUTIONS
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